Manulife (Manufacturers Life Insurance)’s Utah Medical Products UTMD Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,064	Closed	-$206	–	3190
2021 Q4	$206	Sell	2,064 -442	-18%	-$45.1K	﹤0.01%	2876
2021 Q3	$233K	Sell	2,506 -213	-8%	-$18.8K	﹤0.01%	2875
2021 Q2	$231K	Buy	2,719 +261	+11%	+$22.6K	﹤0.01%	3007
2021 Q1	$213K	Buy	+2,458	New	+$216K	﹤0.01%	2848
2020 Q2	–	Sell	-2,345	Closed	-$221K	–	2932
2020 Q1	$221K	Buy	2,345 +151	+7%	+$14K	﹤0.01%	2259
2019 Q4	$237K	Sell	2,194 -188	-8%	-$19K	﹤0.01%	2482
2019 Q3	$229K	Sell	2,382 -30	-1%	-$2.79K	﹤0.01%	2494
2019 Q2	$231K	Buy	+2,412	New	+$203K	﹤0.01%	2545
2018 Q3	–	Sell	-2,794	Closed	-$309K	–	3842
2018 Q2	$309K	Buy	2,794 +83	+3%	+$8.67K	﹤0.01%	2758
2018 Q1	$268K	Sell	2,711 -233	-8%	-$20.8K	﹤0.01%	2791
2017 Q4	$240K	Sell	2,944 -192	-6%	-$15K	﹤0.01%	2868
2017 Q3	$230K	Sell	3,136 -219	-7%	-$15.8K	﹤0.01%	2867
2017 Q2	$242K	Buy	3,355 +448	+15%	+$29.5K	﹤0.01%	2855
2017 Q1	$181K	Buy	2,907 +271	+10%	+$17.1K	﹤0.01%	2899
2016 Q4	$191K	Sell	2,636 -174	-6%	-$11.3K	﹤0.01%	2824
2016 Q3	$168K	Sell	2,810 -155	-5%	-$9.86K	﹤0.01%	2899
2016 Q2	$187K	Buy	2,965 +43	+1%	+$2.77K	﹤0.01%	2761
2016 Q1	$182K	Buy	2,922 +643	+28%	+$37.9K	﹤0.01%	2668
2015 Q4	$133	Hold	2,279	–	–	﹤0.01%	2953
2015 Q3	$123	Hold	2,279	–	–	﹤0.01%	3027
2015 Q2	$135	Sell	2,279 -349	-13%	-$19.6K	﹤0.01%	3184
2015 Q1	$157	Buy	2,628 +905	+53%	+$53.2K	﹤0.01%	2924
2014 Q4	$104	Buy	1,723 +168	+11%	+$9.3K	﹤0.01%	3056
2014 Q3	$76	Sell	1,555 -1,307	-46%	-$66.4K	﹤0.01%	3193
2014 Q2	$147K	Buy	2,862 +209	+8%	+$10.7K	﹤0.01%	2946
2014 Q1	$154	Buy	2,653 +264	+11%	+$14.4K	﹤0.01%	2873
2013 Q4	$136	Sell	2,389 -71	-3%	-$3.9K	﹤0.01%	2945
2013 Q3	$146	Sell	2,460 -39	-2%	-$2.13K	﹤0.01%	2878
2013 Q2	$136K	Buy	+2,499	New	+$118K	﹤0.01%	2848

Other funds holding UTMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s UTMD Position: Q1 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Utah Medical Products (UTMD) in Q1 2022, closing a stake of 2,064 shares — an estimated $206 sold.

Manulife (Manufacturers Life Insurance) first reported a position in UTMD in Q2 2013 and held it in 29 quarters. The position peaked at $309K in Q2 2018. 85 funds tracked by Wall St. Rank hold UTMD as of Q1 2022.

Manulife (Manufacturers Life Insurance) reported no remaining Utah Medical Products position as of Q1 2022 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 2,064 Utah Medical Products shares in Q1 2022, an estimated $206.
Manulife (Manufacturers Life Insurance) first reported a position in Utah Medical Products in Q2 2013 and held it in 29 quarters.
Manulife (Manufacturers Life Insurance)'s Utah Medical Products position peaked at $309K in Q2 2018.
85 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2022, filed 20 May 2022.